Back to newsFibrobiologics, Inc.: H.C. Wainwright cuts target price to $4 from $6FFBLG•2026-11-20H.C. Wainwright cut its target price for Fibrobiologics to $4 from $6.Related NewsGGold bulls not capitulating... yetGLD•2026-11-20BBath & Body Works target price cut to $21 from $22 by Morgan StanleyBBWI•2026-11-20SWall Street's fear gauge touches seven-month high as AI worries mountSPY•2026-11-20MMentari Therapeutics appoints Deloitte as auditorMTRI•2026-11-20AGBC rates Almonty Industries buy with USD 30 price targetALM•2026-11-20